On December 18, Consul General Takaoka attended a ceremony to make remarks (link) in celebration of the acquisition of Kalon Biotherapeutics, LLC by FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a FUJIFILM and Mitsubishi Corporation joint venture company, at the George Bush Presidential Library in College Station. Participants to the ceremony included Governor Rick Perry, Chancellor of Texas A & M John Sharp, Texas A & M Health Science center CEO Dr. Brett Giroir, FUJIFILM’s President and COO Shigehiro Nakajima, as well as Mitsubishi Corporation (Americas)’s President & CEO Yasuyuki Sugiura.
As a result of this acquisition, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. employs world class technologies for robust, high containment manufacturing, thereby enabling the safe, stable manufacture of vaccines to be used as public medical countermeasures against threats such as pandemic influenza, Ebola and Anthrax. Additionally, Kalon utilizes state-of-the-art mobile clean rooms (MCRs) featuring high containment, compactness and mobility. These MCRs enable concurrent manufacturing of several types of vaccines, as well as all kinds of biopharmaceuticals and antibodies, which will meet the growing demand for high-variety, low-volume manufacturing.